Resistant Hypertension Management

Introduction to Resistant Hypertension

The International Society of Hypertension guidelines recommend adding a thiazide-like diuretic as the next step after optimizing ACE inhibitor/ARB and calcium channel blocker doses, rather than further increasing the ACE inhibitor dose 1.
Patients with resistant hypertension should have a diuretic as part of their three-drug regimen, which is considered a critical component of their treatment 2, 3, 4.

The American Heart Association guidelines recommend thiazide-like diuretics as the third agent before considering a fourth medication class for resistant hypertension 3, 4.
Chlorthalidone or indapamide should be added as a thiazide-like diuretic, with chlorthalidone providing an additional 7-8 mmHg systolic BP reduction compared to hydrochlorothiazide at equivalent doses 3, 4.
The initial dose of chlorthalidone should be 12.5-25 mg daily, and indapamide should be started at 1.25-2.5 mg daily 3, 4.

Moving either the lisinopril or amlodipine to bedtime can help address evening BP elevation, with recent diabetes guidelines suggesting individualized bedtime dosing based on the patient's specific BP pattern 4, 5.

If BP remains elevated after adding a diuretic, spironolactone 12.5-25 mg daily should be added as the most effective fourth-line agent for resistant hypertension 2, 3, 4.
Approximately 70% of resistant hypertension patients are candidates for spironolactone based on kidney function and potassium levels 3, 4.

Serum creatinine and potassium levels should be checked within 1-2 weeks after adding a diuretic and again after adding spironolactone if needed, with monitoring for hyperkalemia risk, especially when combining ACE inhibitors with spironolactone 2, 3, 5.
True resistant hypertension should be confirmed with home BP monitoring or 24-hour ambulatory BP monitoring to exclude white coat effect 1, 3.

Medication adherence should be verified first before escalating therapy, as non-adherence is a common cause of apparent resistant hypertension 2, 3.
Secondary hypertension causes should be considered if BP remains uncontrolled despite optimal four-drug therapy, with beta-blockers typically reserved as fifth-line agents unless there's a specific indication like heart failure or prior MI 1, 3, 4.